Clinical trial Recruiting at 12 sites Interventional Ages 0 Months to 60 Months

Managing breath-holding spells in young children

Official title: Breath-holding Spells and Its Management: a Prospective Study on Patient and Disease Characteristics, Evaluation of Novel Guidelines, Parental Handling, and Long-term Follow-up in Breath-holding Spells

Run by Region Skane · NCT06628271 · Data updated 2026-11-12

This study tests new guidelines for helping young children with breath-holding spells to see if they can reduce unnecessary tests and improve care, while also checking if giving iron supplements can help lessen these spells.

Quick facts

Study typeInterventional
Ages0 Months to 60 Months
SexAll
Enrollment120 (estimated)
SponsorRegion Skane
Academic / other
Locations12 sites (Eslöv and 11 other locations)
StatusRecruiting
StartedDecember 2, 2024
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedMay 5, 2026
Trial IDNCT06628271 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children under five years old who are residents of Region Skåne and suspected of having breath-holding spells.

Probably not a fit

Patients who have previously been investigated for breath-holding spells may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates new guidelines for diagnosing and managing breath-holding spells in children under five years old in southern Sweden. It aims to determine if these guidelines can reduce unnecessary diagnostic interventions and ensure safe clinical management. Additionally, the study investigates whether iron supplementation can decrease the frequency and severity of these spells. Parents will also be surveyed to understand their informational and support needs regarding their children's condition.

Why it matters

Potential benefit: If successful, this study could lead to improved management and reduced frequency of breath-holding spells in young children.

How similar studies have gone: While this approach is novel in its specific focus, similar studies have shown promise in managing pediatric conditions through updated guidelines.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Below 5 years of age
* resident in Region Skåne (Sweden)
* suspected breath-holding spell

Exclusion Criteria:

* previous investigation for breath-holding spell (previous spells are not a reason for exclusion)

Where it's running

  • Barn- och ungdomsmedicinmottagning Eslöv
    Eslöv, Sweden
    Recruiting
  • Capio Barnavårdscentral Kristianstad
    Kristianstad, Sweden
    Recruiting
  • Barnläkargruppen Sparta
    Lund, Sweden
    Recruiting
  • Skåne University Hospital
    Lund, Sweden
    Recruiting
  • Barnläkargruppen Sparta
    Malmö, Sweden
    Recruiting
  • BVC Bambino Hyllie
    Malmö, Sweden
    Recruiting
Show 6 more locations
  • BVC Bambino Lindängen
    Malmö, Sweden
    Recruiting
  • BVC Bambino Mobilia
    Malmö, Sweden
    Recruiting
  • Skåne University Hospital
    Malmö, Sweden
    Recruiting
  • Barn- och ungdomsmedicinmottagning Simrishamn, Capio närsjukhus
    Simrishamn, Sweden
    Recruiting
  • Familjecentralen Björken, BVC Sjöbo
    Sjöbo, Sweden
    Recruiting
  • Lasarettet i Ystad
    Ystad, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.